Roundup Cancer Lawsuit News

Scientific Studies Challenged in DeWayne Johnson Monsanto Cancer Trial

Attorneys for DeWayne Johnson challenge the EPA's findings that glyphosate is safe for humans

Tuesday, July 31, 2018 - As the trial alleging Roundup herbicide caused his cancer enters week four, attorneys for the plaintiff DeWayne Johnson now argue that Monsanto submitted, "fraudulent cancer data" in order to have glyphosate approved in the mid-1970's to US government agencies. The data that was used to approve glyphosate's designation as safe was later found to have discrepancies. The company that conducted the glyphosate safety study is now out of business and the top executives were convicted of fraud for "routinely falsifying data." Johnson's attorneys allege " Monsanto knowingly submitted fraudulent data to get around the EPA's licensing requirements." Johnson's attorneys have also pointed to a study conducted in 1983 that prompted the FDA to originally classify glyphosate as a carcinogen in humans. Monsanto is accused of using their contacts within the EPA to suppress scientific evidence and to have the conclusions of this and other studies overturned. (1)

Monsanto is quick to point out that there is no credible US government agency that has studied glyphosate and concluded that glyphosate is carcinogenic in humans. Attorneys for the company also stated there wasn't a single lawsuit against Monsanto claiming that Roundup caused a person's cancer until the IARC published their opinion that glyphosate was, "probably carcinogenic." Monsanto claims that the agency's glyphosate cancer designation was due to one of their consultants working for a law firm that intended to sue Monsanto alleging Roundup caused their client's cancer and would base their case on the IARC's cancer designation. Monsanto also has claimed that the IARC picked only the research that fit their pre-determined conclusion that glyphosate is carcinogenic.

Spokespersons for the IARC have countered the accusations that their glyphosate cancer findings are tarnished by stating "The IARC does not base its evaluations on opinions presented in media reports. Instead, (the group) conducts evaluations of carcinogenicity based on the systematic assembly and review of all publicly available and pertinent scientific studies, by independent experts, free from vested interests." (2)

Monsanto has billions of dollars riding on the outcome of the DeWayne Johnson Monsanto cancer trial. A San Francisco judge recently green-lighted thousands of glyphosate cancer trials, mostly from workers in high-risk occupations such as farming, landscaping and government property maintenance. Those suing Monsanto have hired Roundup cancer lawyers in order to file a claim against the company seeking reimbursement of their medical expenses, lost income, and pain and suffering.

Plaintiffs like DeWayne Johnson claim their regular use and direct exposure to Roundup caused non-Hodgkin's lymphoma, a rare form of cancer. Johnson has testified in court that he did not use a protective waterproof suit when spraying Roundup and on occasions was "soaked" in the chemical. The skin on Johnson's entire body is covered in open cancerous lesions that the plaintiff claims are the result of the direct contact with Roundup herbicide. Scientists have testified on behalf of Johnson and stated that they have conducted scientific studies that show glyphosate bioaccumulates on the skin.




More Recent Roundup Cancer Lawsuit News:

Lawyers for Roundup Cancer Lawsuits

Attorneys handling Roundup cancer lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Roundup cancer lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Roundup cancer lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.